Reuters logo
BRIEF-Cadila Healthcare says no 483 observation was issued by USFDA on co's topical mfg facility
April 7, 2017 / 9:07 AM / 8 months ago

BRIEF-Cadila Healthcare says no 483 observation was issued by USFDA on co's topical mfg facility

April 7 (Reuters) - Cadila Healthcare Ltd

* Cadila’s topical manufacturing facility successfully completes USFDA inspection

* Says no observation (483) was issued Source text: (bit.ly/2oQ2bYt) Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below